Brittany Barreto has expanded her DNA dating technology to a compatibility company named We Have Chemistry. Courtesy of WeHaveChemistry

As Brittany Barreto was developing and promoting her DNA-based dating app, Pheramor, that can establish compatibility in prospective couples using a certain string of genetics, she made some couples very jealous. While not single, they wanted to know the compatibility they have with their partner.

"For every single we connected with through Pheramor, there were at least three couples that wanted to complete the DNA swab to find out their compatibility," she says in a news release.

Now, Barreto and her team, which now includes acclaimed relationship expert Laura Berman, have developed WeHaveChemistry, a series of tests and DNA analysis that can give couples a look at their compatibility. And, WeHaveChemistry has taken it a step further to include more than just DNA in the report.

"The team is very excited about WeHaveChemistry," says Barreto in the release. "We've done our research and carefully crafted two reports: the socioemotional analysis and the DNA report. All couples will receive both reports to analyze their physical and emotional chemistry—which we refer to as their 'Love Alchemy."

The results aren't categorized as good or bad, and there's no score determined for couples — the findings are meant to be used to enhance the relationship and as a guide for navigating the trials and tribulations that often come with monogamy.

"The most important way for couples to ensure that their relationship stays strong is to both play to their strengths and to be honest and curious about their areas for growth," says Berman in the release. "We all have areas where we need to stretch a little, both as partners and as people, and couples can apply the findings of the SEA to their relationships and begin growing right away. In addition, the SEA identifies where we are strongest, what we should celebrate and honor, and the areas which we can rely on as a firm foundation when times get tough."

The process goes as follows:

  • Couples complete the DNA kit.
  • Each person takes the socioemotional analysis quiz, which analyzes emotional intimacy, physical connection, purpose, and future vision. The quiz will identify the person's strengths.
  • Each person receive their DNA report, which assesses sexual chemistry based on genetics.
  • The two aspects — the DNA report and the quiz results — are combined to predict and guide chemistry.

The way genetics affects attraction is completely subconscious and instinctual, dating back to primitive times.

"The science behind attraction based on your DNA is that people are attracted to one another when their immune systems are different — opposites attract is biologically true," Barreto says in a previous InnovationMap article. "When we were cavewomen and cavemen, we didn't know who was our uncle and who was our cousin, so we used our nose to figure out who is genetically diverse compared to us. If you're genetically diverse, then you're probably not my relative, and therefore we'd have healthier children."

Of course, nowadays, there are many more factors that go into compatibility and both Pheramor and WeHaveChemistry have included that in their assessments.

Swabbing for love

Courtesy of WeHaveChemistry

The DNA kit has swabs and information for two people and is sent through the mail.




Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston healthtech startup raises $30M to scale surgical healing gel

fresh funding

Houston-based healthtech startup TYBR Health has raised a $30 million Series A round to scale its B3 GEL System, which helps protect tendons from scarring after surgery.

The round was led by Minneapolis-based Vensana Capital and Cleveland-based Mutual Capital Partners, with participation from Denver-based Neovate Capital Partners and existing investors, according to a news release from the company.

TYBR Health said it plans to use the funding to broaden the B3 GEL System's clinical applications, expand commercialization and conduct studies to evaluate its ability to protect tissue and improve healing outcomes.

"Surgeons are exceptionally good at the structural repair, but the biology that follows is what determines how it heals. That part of the equation has gone largely unaddressed ... There's a shift underway across surgical specialties, from focusing almost entirely on the mechanical repair to also weighing the biological conditions that repair needs to succeed," Tim Keane, co-founder and CEO of TYBR Health, said in the news release. "This financing lets us reach more surgeons and generate the clinical evidence to move that shift forward."

As part of the financing round, Greg Banker of Vensana Capital and Liz Todia Zambory of Mutual Capital Partners will join the TYBR board, alongside independent director Aaron Smith.

"TYBR Health is addressing a gap surgeons have lived with for a long time, with a product that fits the way they already work," Zambory, principal at Mutual Capital Partners, added in the release. "We're excited to co-lead this round and support the company's growth."

TYBR was founded in 2020 and originated from the TMCi’s Biodesign fellowship and participated in the TMC's Accelerator for HealthTech. Its B3 GEL System is a flowable extracellular matrix hydrogel designed to protect tendons, ligaments, muscles, and the surrounding soft tissue while they heal from orthopedic surgery. It received FDA 510(k) clearance last June and launched an Australian clinical trial in the fall.

The B3 GEL System has been used in hand, wrist, shoulder, foot and ankle, and sports medicine procedures since it launched, according to the company, and was first used in the clinical setting earlier this year by Dr. Tammam Hanna with Texas Tech University Health Sciences Center.

Houston space companies win NASA funding to build Mars exploration robots

mission to mars

Two Houston-area spacetech companies have landed a portion of a $17 million award from NASA to develop robots for exploring the surface of Mars, the agency announced this month.

Houston-based Inuitive Machines and Webster, Texas-based MEI Technologies, which does business as Aegis Aerospace, were among the seven companies selected to receive the funding from NASA's Science Transport and Robotic Innovation for Deployment and Exploration (STRIDE) initiative.

According to the release from NASA, the companies are tasked with creating "innovative mobility systems" that would allow future Mars missions to access more challenging terrain and difficult-to-reach regions of the planet, and to travel farther distances. NASA estimated that the work will begin this fall.

NASA solicited proposals for participants in the STRIDE initiative in January. The seven named companies are the first selected to participate in the program.

The additional five companies to receive STRIDE funding include:

"STRIDE demonstrates NASA’s commitment to strong public-private partnerships, allowing the agency to explore new approaches for Mars surface exploration while identifying key capability gaps and development needs for commercial systems that could operate and traverse realistic Martian environments," NASA shared in the announcement.

Last month, Intuitive Machines was awarded $148.3 million to deliver its Nova-C lander to the moon. The funding was part of $600 million the space agency awarded to three companies as part of its Moon Base Program and was Intuitive Machines' sixth task order under NASA's Commercial Lunar Payload Services (CLPS) program. Astrobotic was also one of the companies to land funding for the Moon Base program, as well as Austin-based Firefly Aerospace.

Around the same time, Firefly Aerospace was awarded a $13 million subcontract from NASA’s Jet Propulsion Laboratory to develop technology for NASA’s SkyFall mission to Mars. The mission aims to deploy three Mars helicopters to "perform science and demonstrate airborne subsurface mapping and resource prospecting on the planet." Read more here.